tegretol 200mg tablet
novartis corporation (malaysia) sdn. bhd. - carbamazepine -
tegretol cr 400mg tablets
novartis corporation (malaysia) sdn. bhd. - carbamazepine -
tegretol tablets 200mg
novartis pharma services inc 46057 00100 nairobi - carbamezapine - tablet - 200mg - antiepileptics: carboxamidederivatives
tegretol
novartis new zealand ltd - carbamazepine 20 mg/ml; ; - syrup - 100 mg/5ml - active: carbamazepine 20 mg/ml excipient: caramel hyetellose macrogol stearate 400 methyl hydroxybenzoate powdered cellulose propyl hydroxybenzoate propylene glycol purified water saccharin sodium sorbic acid sorbitol - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures
tegretol
novartis new zealand ltd - carbamazepine 20 mg/ml; - syrup - 100 mg/5ml - active: carbamazepine 20 mg/ml excipient: caramel hyetellose macrogol stearate 400 methyl hydroxybenzoate powdered cellulose propyl hydroxybenzoate propylene glycol purified water saccharin sodium sorbic acid sorbitol - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures
tegretol 100mg chewtabs
novartis pharmaceuticals uk ltd - carbamazepine - chewable tablet - 100mg
tegretol 200mg chewtabs
novartis pharmaceuticals uk ltd - carbamazepine - chewable tablet - 200mg
tegretol liquid carbamazepine 20 mg/ml oral liquid bottle
novartis pharmaceuticals australia pty ltd - carbamazepine, quantity: 20 mg/ml - oral liquid, suspension - excipient ingredients: hyetellose; methyl hydroxybenzoate; purified water; dispersible cellulose; propyl hydroxybenzoate; sorbitol solution (70 per cent) (non-crystallising); peg-8 stearate; sorbic acid; propylene glycol; saccharin sodium; flavour - 1. epilepsy: complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalisation; generalised tonic-clonic seizures; mixed seizure patterns incorporating the above. tegretol is suitable for monotherapy and combination therapy. tegretol is usually not effective in absence seizures, atonic seizures and myoclonic seizures and should not be used for status epilepticus (see "precautions"). 2. trigeminal neuralgia: for relief of pain in idiopathic trigeminal neuralgia and trigeminal neuralgia due to multiple sclerosis; and in idiopathic glossopharyngeal neuralgia. (tegretol is not a simple analgesic and is not intended for trivial facial pain or headache). 3. mania and bipolar affective disorders: treatment of mania and maintenance treatment of bipolar affective disorders to prevent or attenuate recurrence.
deptran 50 hexagonal tablet blister pack
alphapharm pty ltd - doxepin hydrochloride, quantity: 56.5 mg (equivalent: doxepin, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; lactose monohydrate; carnauba wax; purified talc; sodium starch glycollate; diethyl phthalate; magnesium stearate; titanium dioxide; indigo carmine; erythrosine; povidone - the 50mg and 75mg tablets are indicated only for the maintenance treatment of major depression. (see precautions).
pms-carbamazepine-cr tablet (extended-release)
pharmascience inc - carbamazepine - tablet (extended-release) - 400mg - carbamazepine 400mg - miscellaneous anticonvulsants